Reimbursed with a limitationOriginator productATC A10AE56

Xultophy

Xultophy is an originator product from Novo Nordisk Pharma AG and is listed on the FOPH Specialities List. Swiss mandatory health insurance therefore reimburses it within the authorised indication. The public price ranges from CHF 143.55 to CHF 143.55 depending on the pack; the patient co-payment is 10 per cent plus the deductible.

Core data

Authorisation holder
Novo Nordisk Pharma AG
ATC code
A10AE56
IT group
07.06.10 Insuline
Active substances
Insulinum degludecum, Liraglutidum
Preparation type
Originator product
On the SL since
01/11/2014
Last price change
01/04/2024
Co-payment
10%

Prices per pack

The ex-factory price is the authorisation holder's price; the public price adds the distribution share and VAT. Both are FOPH maximum prices: nothing above them may be charged.

Xultophy Price table As of 17/09/2026
Dosage formPack sizeEx-factory pricePublic priceValid fromCat.GTIN
Inj Lös 100E/ml 3.6 mg/ml3 Fertpen 3 mlCHF 116.91CHF 143.5501/11/2014B7680650410058

Limitation

This preparation is reimbursed only under the conditions below. The text is the binding FOPH wording; outside those conditions basic insurance does not pay.

The FOPH publishes limitation texts in German, French and Italian only. The German wording is reproduced verbatim below.

FOPH wordingValid from 01/11/2014

Xultophy wird in Kombination mit Metformin oder mit Metformin plus einem Sulfonylharnstoff zur Behandlung des Typ 2 Diabetes mellitus bei Erwachsenen angewendet, wenn Metformin allein, Metformin in Kombination mit einem Sulfonylharnstoff oder Metformin in Kombination mit einem Basalinsulin keine adäquate Blutzuckerkontrolle gewährleisten.
Mindestens BMI 28.
Zusätzliche Medikamente zur Gewichtsreduktion werden nicht vom Krankenversicherer vergütet.

FAQ

Is Xultophy covered by Swiss health insurance?

Yes, but only under conditions. Xultophy is on the Specialities List with a limitation: basic insurance reimburses it only when the conditions in the limitation text are met, in some cases only after the insurer has granted cost approval.

What does Xultophy cost in Switzerland?

The public price is the maximum price set by the FOPH and for Xultophy ranges from CHF 143.55 to CHF 143.55 per pack. The ex-factory price ranges from CHF 116.91 to CHF 116.91. Pharmacies may not charge more, but may charge less.

Correct or complete this entry

Market access

Do you need your product on the Specialities List?

Questions about SL listing, prices or limitations? Contact Swiss Reimbursement.

  • Independent directory
  • Official FOPH data
  • Website in eight languages
Send an enquiry
Contact

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissreimbursement.com